Skip to content

13F-HR filed by Atlas Venture Advisors, Inc.

Atlas Venture Advisors, Inc. filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-01-31, with 7 holding rows worth $289,908,296.

Accession
0001104659-23-008292
Filed
2023-01-31
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2022

A holdings report, 7 entries on the cover page, a total value of $289,908,296 stated on the cover page (in dollars after the unit check, H1), rows summing to $289,908,296 with VALUE read as dollars as filed, 13F file number 028-19068. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
INTEGRAL AD SCIENCE HLDNG CO45828L108COM22,722,771$199,733,157dollars as filed
DRAFTKINGS INC NEW26142V105COM CL A6,555,608$74,668,375dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM209,505$6,119,641dollars as filed
F-STAR THERAPEUTICS INC30315R107COM574,996$3,633,975dollars as filed
ROKU INC COM CL A77543R102Stock57,707$2,348,675dollars as filed
SNAP INC83304A106CL A245,559$2,197,753dollars as filed
LARIMAR THERAPEUTICS INC517125100COM292,184$1,206,720dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-23-008292this filing2023-01-31acceptance time not in the bulk data set